The energy charge potential of the cerebral adenylate system, the cerebral lactate: pyruvate system, and the cerebral glycogen level were used to characterize the cerebral energy state of the brain. Cerebral adenyl cyclase activity and cyclic AMP concentrations were investigated to evaluate their possible influence on the regulatory processes in brain metabolism. These biochemical parameters were evaluated on the cortical motor area of the brain of the beagle dog in hypovolaemic hypotension during acute hypoxia (obtained by altering the composition of the inhalation mixture) and during the post-hypoxic recovery (three minutes after the restoration of normal ventilation). This experimental model of acute hypoxia was also used for investigating the action of some substances acting at /-adrenergic receptor level or at vascular level. The substances were perfused into the carotid artery at the rate of 0.5 ml/min for three to six minutes. During the first stage of hypoxia, the adenyl cyclase system is probably an important biochemical regulatory factor. This system becomes less important when a critical threshold is crossed (oxygen arterial partial pressure < 25-20 mmHg) below which other factors become rate-limiting. A 13-receptor stimulating agent enhanced the mechanisms of physiological post-hypoxic recovery; inhibition of this action was obtained with a f-receptor blocking agent. Under these experimental conditions, no correlation existed between the vascular effects of the agents and brain metabolism.
of cyclic AMP in response to catecholamines (Stock and Westermann, 1966; Butcher and Sutherland, 1967) . Adenyl cyclase from the brain, localized in a particulate fraction (De Robertis et al., 1967) , has been extracted through lyophilization and lipid extraction with the retention of catecholamine sensitivity and has been partially solubilized . Also, the formation of cyclic AMP was stimulated in the cortical and cerebellar tissues not only by catecholamines (Klainer et al., 1962) , but also by histamine (Kakiuchi and Rail, 1968) .
The phosphodiesterase from the brain (Cheung, 1967) was inhibited by ATP and pyrophosphate, and also by citrate. This action is counteracted by competitive inhibition by methylxanthines (Butcher and Sutherland, 1962; Cheung, 1967) . Cyclic AMP may play a role in the release of acetylcholine from nerve endings (Breckenridge et al., 1967) and this effect, modulated by catecholamines, can be blocked by /3-adrenergic blocking agents (Biver and Goffart, 1965;  G. Benzi anld R. F. Villa Breckenridge et al., 1967) . Nevertheless, a high concentration of a-adrenergic blocking agents also exerts a similar effect (Biver and Goffart, 1965; Bowman and Raper, 1967) . This effect is probably not exerted at the receptor level, but rather results from an interference with the action of cyclic AMP (Northrop and Parks, 1964; Aulich et al., 1967) . There is also evidence that, in some cases, the increase in the concentration of cyclic AMP to levels which seem higher than necessary may be an illustration of the concept of spare receptors (Ariens, 1966; Butcher and Sutherland, 1967; Grahame-Smith et al., 1967) . The purpose of the present work was: (1) to correlate the activity of the adenyl cyclase system with the cerebral energy state (alterations of the cerebral energy charge potential were obtained through a controlled change of arterial oxygen partial pressure during hypovolaemic hypotension in the beagle dog); (2) to test the effect on the adenyl cyclase system of agents exhibiting an affinity for P-adrenergic receptors, and exerting either a mimetic-for example, bamethan-or lytic-for example DCI-action. In situ P-mimetic compounds often show a vasodilating power which can modify the metabolic state of the tissue. For the sake of comparison, the vasodilating substance papaverine, which exerts a direct action on smooth muscle fibres, was also used. The activity of the adenyl cyclase system of the brain was evaluated through both the enzyme activity and the cyclic AMP concentration. Nilsson, 1971) . Therefore, the hypoxia experiments were carried out on beagle dogs in hypovolaemic hypotension lasting 22 to 30 minutes. In fact, it is possible that regulatory mechanisms allow near normalization of the energy state when hypotension is prolonged (Holmin et al., 1974) .
After the operative procedure a period of 30 minutes was allowed before hypotension was induced. The dogs were slowly bled from the arterial femoral cannula into a heparinized Wolfe bottle. A mean blood pressure of 60 mmHg was attained within eight to 20 minutes and then cautious arterial withdrawals or venous infusions by a peristaltic pump were made so that the mean blood pressure was held as constant as possible for 25 minutes. Normally, the blood pressure could be held at the specified level to within ± 4.0 mmHg. If large variations occurred or if a substantial part of the blood had to be reinfused to keep the blood pressure constant, the dog was discarded.
The experiments were carried out by evaluating the cerebral biochemical parameters in dogs before, during, and after arterial hypoxaemia. The three periods in each experiment were usually: (1) steadystate period of hypovolaemic hypotension of 10 minutes, during air ventilation; (2) six to 12 minutes of acute hypoxia induced by altering the inspired oxygen concentration with a 6% or a 4°/ oxygennitrogen mixture in the respirator. Saline solution or drugs were perfused through the superior thyroid arteries during the last six minutes of hypoxia, at the rate of 0.5 ml/min, at the molar concentration indicated below; (3) three minutes of recovery of respiration with air, and perfusion through the superior thyroid arteries with saline solution or drugs.
ANALYTICAL TECHNIQUES At the set time, the motor area of the cortex was frozen in situ by pouring liquid nitrogen into the plastic funnel fitted into the cranial vault. Ventilation with air or with oxygennitrogen mixture was continued for at least two minutes after the beginning of the regional brain freezing. A portion of the frozen brain was chiselled out using a rotating cold hollow tube during continuous irrigation with liquid nitrogen. The frozen cerebral material was then immersed into liquid nitrogen for 10 to 15 minutes and was subsequently extracted with perchloric acid. The initial extraction was performed at from -100 to -15°C, using frozen 3 M perchloric acid, while the subsequent steps were carried out at 0-50C until a neutral perchlorate-free extract was obtained. The Schmahl et al. (1965) . Samples for the cyclic AMP assays were prepared from the cerebral frozen tissue by extraction and purification procedures involving ion-exchange column chromatography with two fractionation systems, according to Butcher et al. (1965) . The activities of the adenyl cyclase system were evaluated by determining the rate of cyclic AMP produced in the assay mixture, according to De Robertis et al. (1967) . Each value was calculated from the mean of at least four determinations performed blind on the same sample.
SUBSTANCES USED The following substances were perfused into the carotid arteries, at the indicated molar concentration: (1) 1-(p-hydroxyphenyl)-2-butylaminoethanol: bamethan= 2.5 x 10-4M; (2) 1-(3,4-dichlorophenyl)-2-isopropylamino-ethanol hydrochloride: DCI= 5 x 10-4 M; (3) 6,7-dimethoxy-l-veratrylisoquinoline hydrochloride: papaverine =5x 10-4 M.
CEREBRAL ENERGY CHARGE POTENTIAL According to Atkinson (1968) (Table 1) , the intracarotid perfusion of the /3-adrenergic stimulating agent bamethan (Table 1) caused an increase in the adenyl cyclase activity, but not a concomitant increase in the cyclic AMP concentration; the cerebral energy charge potential remained highly depressed. The intracarotid perfusion of the ,B-adrenergic blocking agent DCI exerted no effect on the biochemical changes induced by hypoxaemia. The vasodilator agent papaverine did not affect the drop of the energy charge potential induced by hypoxaemia. Table 2 shows the data evaluated three minutes after the post-hypoxia recovery. The biochemical pattern was shifted and a partial recovery of the cerebral energy charge potential occurred. The redox state of the brain, as measured by the lactate: pyruvate ratio, remained high, thus indicating the persistence of anaerobic mechanism. The perfusion of the /3-adrenergic stimulating agent bamethan induced an increase of the adenyl cyclase activity and the cyclic AMP level. On the contrary, the perfusions of the 3-adrenergic blocking agent DCI and of DCI+ bamethan blocked the recovery of the activity of the adenyl cyclase system. This indicates the importance of a /-adrenergic activation on the energy-coupling processes in vivo. The intracarotid perfusion of the vasodilator agent papaverine exhibited no effect on the biochemical changes induced by the recovery of air ventilation.
DISCUSSION
Before discussing the present results, some limitations should be pointed out. In the first place, the model used was an acute one: consequently, chronic studies might lead to different biochemical adjustments. Secondly, these data refer to the motor area of the cerebral cortex: therefore, other important areas of the brain might undergo different biochemical adjustments, because of the anatomical and functional heterogeneity of the brain.
In a first stage induced by hypoxaemia, at values of arterial 02 partial pressure higher than 25 mmHg, the activation of the cerebral adenyl cyclase system seems to be a very important biochemical way for increasing glycogen metabolism, its utilization beilng strongly modulated by both the enzyme activity and the cyclic AMP level. The increase of the lactate: pyruvate ratio in the cerebral tissue is a function of the decrease of arterial oxygen pressure.
In a second stage induced by hypoxaemia, at values of arterial 02 partial pressure lower than 20 mmHg, a critical threshold was probably exceeded, new biochemical conditions were established, and other biochemical mechanisms of regulation were involved. In fact, the adenyl cyclase system was cut off, while carbohydrate catabolism was high, as indicated by the very high lactate production, by the very high lactate: pyruvate ratio, and by the further glycogen reduction. In any case the low ATP levels reduced the substrate for cyclic AMP formation, while they enhanced the rate of transformation from inactive to active phosphofructokinase. On the other hand, the phosphorylase activation can be supported by tissue factors-for example, the kinase activating factor. In any case, during this condition, the 3-adrenergic stimulation, the /3-adrenergic block or the vasodilatation exhibited no action on the cerebral energy charge. This indicates that the physiological autoregulation and feed-back phenomena overcome exogenous interventions. The fl-adrenergic stimulation can induce an increase in the adenyl cyclase activity but not an increase in the cyclic AMP level, probably because of the impairment of ATP.
During the post-hypoxic restoration, the cerebral energy charge potential exhibited a gradual recovery. The high lactate:pyruvate ratio indidicated that the mechanism involved in the recharging of the adenylate pool was still partially anaerobic. Perfusion with a fl-receptor stimulating agent potentiated the adenyl cyclase system and increased the cerebral level of cyclic AMP. Perfusion of a P-receptor blocking agent inhibited the activation by a f-stimulating agent. This fact is probably related to the block of the adenyl cyclase receptor, the adenyl cyclase protein being regarded as a f-adrenergic receptor (Robison et al., 1967) . No correlations exist between the vasodilator effect and the recovery of the cerebral energy-coupling systems. Though a strong vasodilator, papaverine proved unable to affect favourably the restoration of the cerebral energy charge potential.
In conclusion, the data obtained indicate that the adenyl cyclase system is an important cerebral biochemical regulatory factor, but that this system becomes less important beyond a critical threshold of arterial oxygen partial pressure (lower than 25-20 mmHg). Under these conditions, other enzymatic systems-for example, phosphofructokinase-intervene as rate-limiting factors in glycolysis. Consequently, during hypoxaemia the cerebral adenyl cyclase system seems to play a role as an activating factor, but is unable to sustain the activating step for long periods of time beyond a P02 critical threshold.
